Search Results - "Shrestha, Sulena"

Risk of Venous Thromboembolism after New Onset Heart Failure by Smilowitz, Nathaniel R., Zhao, Qi, Wang, Li, Shrestha, Sulena, Baser, Onur, Berger, Jeffrey S.

“…New-onset heart failure (HF) is associated with cardiovascular morbidity and mortality. It is uncertain to what extent HF confers an increased risk of venous…”
Get full text

Cytoreductive treatment patterns among US veterans with polycythemia vera by Parasuraman, Shreekant, Yu, Jingbo, Paranagama, Dilan, Shrestha, Sulena, Wang, Li, Baser, Onur, Scherber, Robyn

“…Polycythemia vera (PV) is a myeloproliferative neoplasm associated with increased thrombotic and cardiovascular risk, which are key contributors to patient…”
Get full text

Effect of Renal Function on Dosing of Non–Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation by Shrestha, Sulena, Baser, Onur, Kwong, Winghan Jacqueline

“…Background: Non–vitamin K antagonist direct oral anticoagulants (DOACs) are fixed-dose regimens indicated for stroke prevention in nonvalvular atrial…”
Get full text

Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases by Shrestha, Sulena, Miao, Raymond, Wang, Li, Chao, Jingdong, Yuce, Huseyin, Wei, Wenhui

“…Introduction Comparative data on the burden of atopic dermatitis (AD) in adults relative to the general population are limited. We performed a large-scale…”
Get full text

Pediatric Focal Epilepsy: Patient Characteristics, Treatment Choices, Healthcare Resource Use and Costs by Developmental Delay and Behavioral Disorders Comorbidity Subgroups: A US Claims Database Analysis (P2.5-035) by Thieffry, Solene, Borghs, Simon, Wang, Li, Shrestha, Sulena, Foskett, Nadia

“…Abstract only…”
Get full text

Burden of CRAB Events By Relapse in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Stem Cell Transplant by Pandya, Shivani, Clancy, Zoe, Shrestha, Sulena, Wang, Li, Baser, Onur

“…▪ Background: For decades, CRAB criteria (hypercalcemia, renal impairment, anemia, and bone disease) have been used to diagnose multiple myeloma (MM), but…”
Get full text

Burden of Autoimmune Disorders Among Patients With Hereditary Angioedema in the United States by Tachdjian, Raffi, Borra, Sujana, Shrestha, Sulena, Wang, Li, Chiao, Joseph, Supina, Dylan, Patel, Ami

Get full text

Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data by Parasuraman, Shreekant, Yu, Jingbo, Paranagama, Dilan, Shrestha, Sulena, Wang, Li, Baser, Onur, Scherber, Robyn

“…Patients with polycythemia vera (PV) have a high incidence of thrombotic events (TEs), contributing to a greater mortality risk than the general population…”
Get full text

Abstract TMP102: Inappropriate Dosing of Oral Anticoagulants among Patients With Non-Valvular Atrial Fibrillation by Shrestha, Sulena, Baser, Onur, Zhou, Xinxiang, Kwong, W J

“…Abstract only Introduction: Non-vitamin K antagonist oral anticoagulants (NOACs) are fixed dose regimens indicated for stroke prevention in non-valvular atrial…”
Get full text

Emerging treatment patterns and checkpoint inhibitor (CPI) use among newly diagnosed Merkel cell carcinoma (MCC) patients in the United States veteran population by Zheng, Ying, Pandya, Shivani, Yu, Ting, Kearney, Mairead, Shrestha, Sulena, Wang, Li, Kim, Ruth, Phatak, Hemant

“…Abstract only 139 Background: MCC is a rare and aggressive skin cancer with annual incidence of 2,500 in the U.S. Checkpoint inhibitors (CPIs) demonstrated…”
Get full text

Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective Analysis by Huang, Qing, Borra, Sujana, Li, Jieni, Wang, Li, Shrestha, Sulena, Sundaram, Murali, Janjan, Nora

“…Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is the most common adult leukemia, accounting for ≈ 37% of all leukemias in the United…”
Get full text

Elevated White Blood Cell Levels and Thrombotic Events in Patients with Polycythemia Vera: A Real-World Analysis of Veterans Health Administration Data by Parasuraman, Shreekant, Yu, Jingbo, Paranagama, Dilan Chamikara, Shrestha, Sulena, Wang, Li, Baser, Onur, Scherber, Robyn Marie

“…Introduction: Patients with polycythemia vera (PV) have poor overall survival compared with the general population, with arterial and venous thrombotic events…”
Get full text

Real-world economic outcomes of early progression in newly diagnosed multiple myeloma (NDMM) patients (Pts) by Clancy, Zoe, Pandya, Shivani, Shrestha, Sulena, Wang, Li, Baser, Onur, Ni, Quanhong

“…Abstract only 194 Background: Despite improved survival with advanced multiple myeloma (MM) treatments (Tx), 15–20% of pts experience early relapse. We…”
Get full text

Hereditary Angioedema and Pregnancy Complications and Outcomes in a Population-Based Cohort by Patel, Ami, Treadwell, Marjorie, Borra, Sujana, Shrestha, Sulena, Machnig, Thomas, Chiao, Joseph, Bonagua, Ellen, Wang, Li, Hsu, Florence

Get full text

Economic burden of early progression in newly-diagnosed multiple myeloma patients by Pandya, Shivani, Clancy, Zoe, Shrestha, Sulena, Wang, Li, Ni, Quanhong, Baser, Onur

“…Abstract only…”
Get full text

First-line Ibrutinib Treatment is Associated with Longer Time to Next Treatment in a Real-World US Veterans Population by Huang, Qing, Ellis, Lorie, Wang, Li, Shrestha, Sulena, Sundaram, Murali

Get full text

Elevated White Blood Cell Levels and Thrombotic Events in Patients With Polycythemia Vera: A Real-World Analysis of Veterans Health Administration Data by Parasuraman, Shreekant, Yu, Jingbo, Paranagama, Dilan, Shrestha, Sulena, Wang, Li, Baser, Onur, Scherber, Robyn

“…Patients with polycythemia vera (PV) have a substantial risk of thrombotic events (TEs). The objective of the present analysis was to describe the association…”
Get full text

Impact of Medicaid antiepileptic drug formulary restrictions on health outcomes and costs (P6.279) by Fishman, Jesse, Shrestha, Sulena, Wang, Li, Yuce, Huseyin, Zorzoli, Joseph, Faught, Edward, Farley, Joel

“…Abstract only…”
Get full text

Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA by Lim, Jonathan, Samuelsen, Carl, Golembesky, Amanda, Shrestha, Sulena, Wang, Li, Griebsch, Ingolf

“…Evaluate duration of therapy among patients treated with afatinib or erlotinib as first-line therapy for non-small-cell lung cancer (NSCLC). NSCLC patients…”
Get full text